Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial.
Lancet
; 396(10264): 1737-1744, 2020 11 28.
Article
in En
| MEDLINE
| ID: mdl-33202219
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Platelet Aggregation Inhibitors
/
Purinergic P2Y Receptor Antagonists
/
Percutaneous Coronary Intervention
/
Ticagrelor
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Lancet
Year:
2020
Document type:
Article
Affiliation country:
France
Country of publication:
United kingdom